US2910111044 - Common Stock
ChartMill assigns a Buy % Consensus number of 81% to EMR. The Buy consensus is the weighted average rating of the current analysts ratings.
Date | Firm | Action | Rating |
---|---|---|---|
2024-04-08 | Citigroup | Maintains | Buy -> Buy |
2024-04-02 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
2024-03-21 | UBS | Maintains | Neutral -> Neutral |
2024-03-06 | Berenberg | Maintains | Buy -> Buy |
2024-03-04 | B of A Securities | Maintains | Buy -> Buy |
2024-02-08 | Mizuho | Maintains | Buy -> Buy |
2024-02-08 | Keybanc | Maintains | Overweight -> Overweight |
2024-02-08 | RBC Capital | Maintains | Outperform -> Outperform |
2024-02-08 | Barclays | Maintains | Equal-Weight -> Equal-Weight |
2024-01-04 | Mizuho | Upgrade | Neutral -> Buy |
2023-12-19 | Wells Fargo | Maintains | Overweight -> Overweight |
2023-11-22 | UBS | Maintains | Neutral -> Neutral |
2023-11-10 | Stephens & Co. | Maintains | Overweight -> Overweight |
2023-11-08 | RBC Capital | Maintains | Outperform -> Outperform |
2023-11-08 | Citigroup | Maintains | Buy -> Buy |
2023-10-03 | UBS | Downgrade | Buy -> Neutral |
2023-10-03 | Keybanc | Initiate | Overweight |
2023-09-15 | Vertical Research | Upgrade | Hold -> Buy |
2023-08-28 | Argus Research | Upgrade | Hold -> Buy |
2023-08-28 | Barclays | Reiterate | Equal-Weight -> Equal-Weight |
2023-08-22 | JP Morgan | Upgrade | Neutral -> Overweight |
2023-08-07 | Stephens & Co. | Reiterate | Overweight -> Overweight |
2023-08-03 | Mizuho | Maintains | Neutral -> Neutral |
2023-08-03 | RBC Capital | Maintains | Outperform -> Outperform |
2023-08-03 | Morgan Stanley | Maintains | Overweight -> Overweight |
2023-07-12 | Morgan Stanley | Reiterate | Overweight -> Overweight |
2023-06-15 | HSBC | Upgrade | Hold -> Buy |
2023-05-08 | Stephens & Co. | Reiterate | Overweight |
2023-05-05 | RBC Capital | Maintains | Outperform |
2023-05-05 | Citigroup | Maintains | Buy |